NTC
ONC

NF Trinity Capital’s BeOne Medicines Ltd ONC Stock Holding History

NF Trinity Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,082
Closed -$454K – 53
2017
Q2 		$454K Buy
+10,082
New +$397K 0.06% 47

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

NF Trinity Capital's ONC Position: Q3 2017 in Review

NF Trinity Capital sold out of BeOne Medicines Ltd (ONC) in Q3 2017, closing a stake of 10,082 shares — an estimated $454K sold.

NF Trinity Capital first reported a position in ONC in Q2 2017 and held it in 1 quarter. The position peaked at $454K in Q2 2017. 81 funds tracked by Wall St. Rank hold ONC as of Q3 2017.

  • NF Trinity Capital reported no remaining BeOne Medicines Ltd position as of Q3 2017 after selling out during the quarter.
  • NF Trinity Capital sold 10,082 BeOne Medicines Ltd shares in Q3 2017, an estimated $454K.
  • NF Trinity Capital first reported a position in BeOne Medicines Ltd in Q2 2017 and held it in 1 quarter.
  • NF Trinity Capital's BeOne Medicines Ltd position peaked at $454K in Q2 2017.
  • 81 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2017.

Based on NF Trinity Capital's 13F filing for Q3 2017, filed 7 Nov 2017.